Maxcyte (MXCT) Current Deferred Revenue (2020 - 2026)
Maxcyte (MXCT) reported Current Deferred Revenue of $2.46 million for Q2 2026, down 6.7% from $2.64 million a year earlier and down 24.7% from the prior quarter.
Powered by 
Analysis
Maxcyte (MXCT) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Maxcyte posted Current Deferred Revenue of $3.6 million, down 31.5% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $5.25 million in FY2024 (+3.6%), $5.07 million in FY2023 (-24.5%), $6.71 million in FY2022 (-0.5%) and $6.75 million in FY2021 (+39.3%).
- The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2020.
- Year over year, Current Deferred Revenue has now declined in each of the last six quarters, with an average decline of 10.9% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2021 (growth of 39.3%); the low point was Q2 2023 (a decline of 35.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.27 million (Q1 2026), $3.6 million (Q4 2025) and $5.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn |
| 10 | Maxcyte | 123.12 Mn | 123.12 Mn | 5.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 2.64 Mn |
| Mar 31, 2025 | 4.15 Mn |
| Dec 31, 2024 | 5.25 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 4.48 Mn |
| Dec 31, 2023 | 5.07 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 6.29 Mn |
| Jun 30, 2022 | 7.31 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Dec 31, 2021 | 6.75 Mn |
| Sep 30, 2021 | 6.33 Mn |
API Access
Maxcyte Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MXCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "MXCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MXCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();